Funded Projects

The American Craft Exposition (ACE) is committed to supporting research and clinical programs at NorthShore University HealthSystem (NorthShore). In 2017, ACE will support leading-edge pharmacogenomics research being conducted at the NorthShore Center for Personalized Medicine, as well as orthopaedic regenerative medicine research being conducted at the NorthShore Orthopaedic Institute.

Share this Page:


Past research projects funded by ACE include:

2016
Karen Kaul, MD

Pharmacogenomics research analyzing how patients react to medications based on genetic variants.


2011-2015
Gustavo Rodriguez, MD

Development of a Progestin-Based Pharmacologic Approach for the Effective Prevention of Ovarian Cancer


2010

Clinical Research Coordinator for Breast and Ovarian Cancer Research


2009

Breast Cancer Research Fellowship


2008
Manjari Dimri, MD

Identification of Oncologic Lesions Involved in Invasive and Refractory Breast Cancer

San Ming Wang, MD

Identifying New Breast Cancer Susceptibility Genes


2007
Jean Hurteau, MD

Progestin and Eicosanoid Combination for Chemoprevention of Ovarian Cancer

Gurumurthy, PhD

hEcd, a Novelmarker for Breast Cancer

Raja Srikumar, PhD

Combinatorial Targeting of ErbB2-HSPop Towards Treatment of ErbB2-related Breast Cancer Tumors


2006
Sofia F. Garcia, Ph.D.

Real-time Symptom Monitoring via Computer Telephony in Patients with Advanced Breast Cancer

Xijin Ge, Ph.D.

Bioinformatics Study on BRCA1 Transcriptional Regulation Mechanisms

Gustavo Rodriguez, MD

Development of a Progestin-Based Chemopreventive Agent for Epithelial Ovarian Cancer


2005
Javier Menendez, MD

Effects of Dietary Fatty Acids in Her-2/neu (erbB-2) Oncogene-Induced Breast Tumorigenesis and Trastuzumab (Herceptin™) Efficacy

David J. Winchester, MD

DNA Microarray Analysis of Multicentric Breast Cancers


2004
Ruth Lupu, MD

Characterization of Heregulin-Induced Activation of HER-2: As A New Molecular target in Breast Cancer

Ruth Lupu, MD

A Possible Prognostic and Therapeutic Value of Cyr61/αvβ3 Integrin


2003
Javier Menendez, MD

Pharmacological Inhibition of Fatty Acid Synthase:A New Therapeutic Approach in Her-2/neu-Overexpressing Breast Cancer

Prem K. Seth, Ph.D.

Gene Therapy for Breast Cancer: Targeting Mutant p53 and TGFβ with Replicating Adenoviruses


2002
Joseph Bass, MD, Ph.D.

Regulation of Receptor Kinase Protooncogene Activity in Breast Cancer Cells

Cheikh Menaa, Ph.D.

Cellular and Molecular Mechanism of Osteoclast Formation and Bone Metastasis Induced by Breast Cancer

David J. Winchester, MD

Endoscopic, Cytologic, and Molecular Analysis of Nipple Aspirates in Women

Susan E. Yount, Ph.D.

Quality of Breast Cancer Care


2001
Stuart Lind, MD

Effects of Coformycin and Adenosine Upon Human Breast Cancer Cells

Douglas Merkel, MD

erbB-2: Clonality and Progression in Recurrence and Metastases

XiaoHe Yang, MD

Breast Cancer Selective and DNA Damage Inducible Caspase 3 Mediated Gene Therapy
A Model of “Tissue Specific and Synchronized Double Hit” Cancer Therapy